Glucose Metabolism Disorders Clinical Trials

15 recruiting

Glucose Metabolism Disorders Trials at a Glance

22 actively recruiting trials for glucose metabolism disorders are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 14 trials, with the heaviest enrollment activity in Aurora, New York, and Chicago. Lead sponsors running glucose metabolism disorders studies include Anne-Sophie Brazeau, BiomeHub Biotechnology Company, and Albert Einstein College of Medicine.

Browse glucose metabolism disorders trials by phase

Treatments under study

About Glucose Metabolism Disorders Clinical Trials

Looking for clinical trials for Glucose Metabolism Disorders? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glucose Metabolism Disorders trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glucose Metabolism Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 22 trials

Recruiting
Phase 2

Regulation of Endogenous Glucose Production by Central KATP Channels

Diabetes MellitusGlucose Metabolism Disorders
Albert Einstein College of Medicine100 enrolled1 locationNCT03540758
Recruiting
Not Applicable

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

Insulin ResistanceHyperinsulinismDepression+5 more
Colorado State University300 enrolled2 locationsNCT05543083
Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting
Not Applicable

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
Anne-Sophie Brazeau200 enrolled4 locationsNCT05910840
Recruiting
Not Applicable

The Effect of Chlorhexidine Mouthwash on Postprandial Glucose Response in Healthy Individuals

Glucose Metabolism Disorders (Including Diabetes Mellitus)
University of Plymouth45 enrolled1 locationNCT07172009
Recruiting

Rare and Atypical Diabetes Network

Diabetes MellitusMetabolic DiseaseEndocrine System Diseases+4 more
University of South Florida2,000 enrolled13 locationsNCT05544266
Recruiting
Phase 2Phase 3

Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational Diabetes

Pregnancy ComplicationsGlucose Metabolism DisordersDiabetes, Gestational+1 more
Jaeb Center for Health Research30 enrolled5 locationsNCT06535789
Recruiting
Not Applicable

Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)

Metabolic DiseaseGestational DiabetesGlucose Metabolism Disorders
KK Women's and Children's Hospital300 enrolled1 locationNCT05081037
Recruiting
Early Phase 1

Metabolic Effects of Endogenous Bile Acids After Gastric Bypass Surgery

Bariatric Surgery CandidateGlucose Metabolism DisordersBile Acid, Elevated Serum
Hvidovre University Hospital18 enrolled1 locationNCT06925997
Recruiting

Glucose Variability and Cognition in Prediabetes

Cognitive DeclineGlucose Metabolism Disorders (Including Diabetes Mellitus)Functional Status
University of Maryland, Baltimore30 enrolled1 locationNCT04201600
Recruiting
Not Applicable

Animal and Plant Proteins and Glucose Metabolism

Metabolic SyndromeGlucose Metabolism DisordersMetabolic Syndrome, Protection Against
University of Missouri-Columbia100 enrolled1 locationNCT03994367
Recruiting
Not Applicable

Food Orders on Blood Glucose and Fuel Use At Rest

Glucose Metabolism DisordersHungerFat Burn
Old Dominion University60 enrolled1 locationNCT06763562
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting
Not Applicable

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM

Metabolic DiseaseDiabetes Mellitus, Type 2Endocrine System Diseases+1 more
Gaia AG250 enrolled1 locationNCT06529965
Recruiting
Not Applicable

Relationship Between Individual Effect of Diet on Postprandial Glycemia and Gut Microbiome Profile in Healthy Subjects

Metabolic DiseaseDiabetesHealth Behavior+1 more
BiomeHub Biotechnology Company80 enrolled1 locationNCT06051318
Recruiting
Not Applicable

Acute Microbial Switch

HyperinsulinismInsulin SensitivityGlucose Metabolism Disorders (Including Diabetes Mellitus)
Maastricht University Medical Center28 enrolled2 locationsNCT05764200
Recruiting
Not Applicable

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

Diabetes MellitusBody WeightMetabolic Disease+9 more
Cornell University60 enrolled1 locationNCT06557317
Recruiting
Phase 1Phase 2

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
CRISPR Therapeutics AG40 enrolled2 locationsNCT05565248
Recruiting
Not Applicable

Glycaemic Index Determination in Oral Nutrition Supplements

Glucose Metabolism Disorders
Universitat de Lleida15 enrolled1 locationNCT06358716
Recruiting
Not Applicable

The Role of Oxytocin in Regulating Blood Glucose

Glucose Metabolism Disorders (Including Diabetes Mellitus)
University Hospital, Gentofte, Copenhagen20 enrolled1 locationNCT06334172